Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: INV002 ×

INV002

This drug is selected. Its supporting articles are shown below.

Articles mentioning INV002

1 articles · page 1 of 1

562 A phase Ia study to assess the safety, tolerability and immunogenicity of a personalized cancer vaccine (InnoPCV/INV002) in patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 1 matching annotations

79.9%

tislelizumab sintilimab InnoPCV INV002 Anti-PD-1 monoclonal antibody non-small cell lung cancer Affiliated Hospital of Guizhou Medical University ECOG Performance Status

… Group performance status of 0 or 1. Eligible patients received tislelizumab (200 mg, IV Q3W) or sintilimab (200 mg, IV Q3W) for a lead-in p…